Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-01 @ 7:00 PM
Study NCT ID:
NCT00248404
Status:
COMPLETED
Last Update Posted:
2022-05-16
First Post:
2005-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)
Sponsor:
Kiadis Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR-TSC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None